The prevalence and nature of antibiotic misuse in a major teaching hospital was assessed by means of a quality-of-use audit. Cefoxitin was chosen for study. The use of cefoxitin increased rapidly during the study period, accounting for 17.7% ($15300) of the pharmacy's costs for cephalosporins during the first year of its availability but 47.7% ($60707) during the second year. Cefoxitin was inappropriately used for 43% of the patients receiving it during the first 2-month audit period and for 25% of those receiving it during the second audit period, 1 year later (p less than 0.01 by chi-square analysis).
Notes
Cites: JAMA. 1970 Jul 13;213(2):264-75467892
Cites: Am J Hosp Pharm. 1972 Oct;29(10):828-345075122
Cites: Ann Intern Med. 1973 Oct;79(4):555-604795880
Cites: JAMA. 1974 Mar 4;227(9):1023-84405926
Cites: Hospitals. 1974 Apr 16;48(8):73-64820315
Cites: J Infect Dis. 1974 Aug;130(2):165-84842338
Cites: Am J Hosp Pharm. 1976 Sep;33(9):918-241086598
Cites: Can Med Assoc J. 1977 Feb 5;116(3):256-9837302
Cites: Hospitals. 1977 Oct 1;51(19):81-2, 84-5903104
Cites: JAMA. 1977 Nov 14;238(20):2170-2578830
Cites: Am J Hosp Pharm. 1978 Dec;35(12):1521-3717407
Cites: Ann Intern Med. 1978 Nov;89(5 Pt 1):650-6362999